These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

609 related items for PubMed ID: 27651273

  • 1. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.
    Fernández-Barat L, Ciofu O, Kragh KN, Pressler T, Johansen U, Motos A, Torres A, Hoiby N.
    J Cyst Fibros; 2017 Mar; 16(2):222-229. PubMed ID: 27651273
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D, Stableforth D.
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [Abstract] [Full Text] [Related]

  • 5. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2015 Mar 05; (3):CD009528. PubMed ID: 25741986
    [Abstract] [Full Text] [Related]

  • 6. Standard versus biofilm antimicrobial susceptibility testing to guide antibiotic therapy in cystic fibrosis.
    Waters V, Ratjen F.
    Cochrane Database Syst Rev; 2017 Oct 05; 10(10):CD009528. PubMed ID: 28981972
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A Low-Molecular-Weight Alginate Oligosaccharide Disrupts Pseudomonal Microcolony Formation and Enhances Antibiotic Effectiveness.
    Pritchard MF, Powell LC, Jack AA, Powell K, Beck K, Florance H, Forton J, Rye PD, Dessen A, Hill KE, Thomas DW.
    Antimicrob Agents Chemother; 2017 Sep 05; 61(9):. PubMed ID: 28630204
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1.
    Riera E, Macià MD, Mena A, Mulet X, Pérez JL, Ge Y, Oliver A.
    J Antimicrob Chemother; 2010 Jul 05; 65(7):1399-404. PubMed ID: 20435779
    [Abstract] [Full Text] [Related]

  • 11. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C, Azcona-Gutiérrez JM, Van Bambeke F, Sáenz Y.
    PLoS One; 2018 Jul 05; 13(9):e0204167. PubMed ID: 30212579
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
    Rees VE, Yadav R, Rogers KE, Bulitta JB, Wirth V, Oliver A, Boyce JD, Peleg AY, Nation RL, Landersdorfer CB.
    Antimicrob Agents Chemother; 2018 Nov 05; 62(11):. PubMed ID: 30104278
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Low-Dose Nitric Oxide as Targeted Anti-biofilm Adjunctive Therapy to Treat Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis.
    Howlin RP, Cathie K, Hall-Stoodley L, Cornelius V, Duignan C, Allan RN, Fernandez BO, Barraud N, Bruce KD, Jefferies J, Kelso M, Kjelleberg S, Rice SA, Rogers GB, Pink S, Smith C, Sukhtankar PS, Salib R, Legg J, Carroll M, Daniels T, Feelisch M, Stoodley P, Clarke SC, Connett G, Faust SN, Webb JS.
    Mol Ther; 2017 Sep 06; 25(9):2104-2116. PubMed ID: 28750737
    [Abstract] [Full Text] [Related]

  • 18. Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis.
    van Mansfeld R, de Been M, Paganelli F, Yang L, Bonten M, Willems R.
    PLoS One; 2016 Sep 06; 11(6):e0158106. PubMed ID: 27337151
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does ivacaftor interfere with the antimicrobial activity of commonly used antibiotics against Pseudomonas aeruginosa?-Results of an in vitro study.
    Millar BC, Rendall JC, Downey DG, Moore JE.
    J Clin Pharm Ther; 2018 Dec 06; 43(6):836-843. PubMed ID: 29959786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.